339 related articles for article (PubMed ID: 23459190)
1. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
Brandau S; Moses K; Lang S
Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
[TBL] [Abstract][Full Text] [Related]
2. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.
Dumitru CA; Lang S; Brandau S
Semin Cancer Biol; 2013 Jun; 23(3):141-8. PubMed ID: 23485549
[TBL] [Abstract][Full Text] [Related]
3. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
Moses K; Brandau S
Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
[TBL] [Abstract][Full Text] [Related]
4. On the cytokines produced by human neutrophils in tumors.
Tecchio C; Scapini P; Pizzolo G; Cassatella MA
Semin Cancer Biol; 2013 Jun; 23(3):159-70. PubMed ID: 23410636
[TBL] [Abstract][Full Text] [Related]
5. Myeloid regulatory cells in tumor spreading and metastasis.
Keskinov AA; Shurin MR
Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
[TBL] [Abstract][Full Text] [Related]
6. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
[TBL] [Abstract][Full Text] [Related]
7. Myeloid cells in cancer-related inflammation.
Caronni N; Savino B; Bonecchi R
Immunobiology; 2015 Feb; 220(2):249-53. PubMed ID: 25454487
[TBL] [Abstract][Full Text] [Related]
8. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.
Peyvandi S; Buart S; Samah B; Vétizou M; Zhang Y; Durrieu L; Polrot M; Chouaib S; Benihoud K; Louache F; Karray S
Cancer Res; 2015 Oct; 75(20):4292-301. PubMed ID: 26359460
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated neutrophils: friend or foe?
Fridlender ZG; Albelda SM
Carcinogenesis; 2012 May; 33(5):949-55. PubMed ID: 22425643
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils: important contributors to tumor progression and metastasis.
Swierczak A; Mouchemore KA; Hamilton JA; Anderson RL
Cancer Metastasis Rev; 2015 Dec; 34(4):735-51. PubMed ID: 26361774
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.
Tazzyman S; Niaz H; Murdoch C
Semin Cancer Biol; 2013 Jun; 23(3):149-58. PubMed ID: 23410638
[TBL] [Abstract][Full Text] [Related]
12. On the origin of myeloid-derived suppressor cells.
Millrud CR; Bergenfelz C; Leandersson K
Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
[TBL] [Abstract][Full Text] [Related]
13. The diversity of circulating neutrophils in cancer.
Mishalian I; Granot Z; Fridlender ZG
Immunobiology; 2017 Jan; 222(1):82-88. PubMed ID: 26874580
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology.
Dumitru CA; Moses K; Trellakis S; Lang S; Brandau S
Cancer Immunol Immunother; 2012 Aug; 61(8):1155-67. PubMed ID: 22692756
[TBL] [Abstract][Full Text] [Related]
16. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
17. Interactions among myeloid regulatory cells in cancer.
Umansky V; Adema GJ; Baran J; Brandau S; Van Ginderachter JA; Hu X; Jablonska J; Mojsilovic S; Papadaki HA; Pico de Coaña Y; Santegoets KCM; Santibanez JF; Serre K; Si Y; Sieminska I; Velegraki M; Fridlender ZG
Cancer Immunol Immunother; 2019 Apr; 68(4):645-660. PubMed ID: 30003321
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
Veglia F; Sanseviero E; Gabrilovich DI
Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.
Brandau S; Trellakis S; Bruderek K; Schmaltz D; Steller G; Elian M; Suttmann H; Schenck M; Welling J; Zabel P; Lang S
J Leukoc Biol; 2011 Feb; 89(2):311-7. PubMed ID: 21106641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
